Ariel Investments - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ariel Investments ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$819,000
-62.7%
237,992
-72.7%
0.01%
-68.0%
Q4 2020$2,195,000
+25.1%
871,112
+4.8%
0.02%0.0%
Q3 2020$1,754,000
+18.8%
831,092
+26.1%
0.02%
+13.6%
Q2 2020$1,477,000
-32.9%
659,316
-24.2%
0.02%
-43.6%
Q1 2020$2,201,000
-13.3%
870,079
-9.9%
0.04%
+21.9%
Q4 2019$2,539,000
-31.3%
965,584
-5.9%
0.03%
-34.7%
Q3 2019$3,695,000
+238.7%
1,026,313
+217.1%
0.05%
+250.0%
Q2 2019$1,091,000323,6150.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2021
NameSharesValueWeighting ↓
HARBERT FUND ADVISORS, INC. 5,175,913$7,246,2785.30%
Potomac Capital Management, Inc. 1,455,000$2,037,0002.60%
TANG CAPITAL MANAGEMENT LLC 2,200,000$3,080,0000.44%
RBF Capital, LLC 250,359$350,5030.02%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$36,0000.02%
Shay Capital LLC 62,500$87,5000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 227,100$317,9400.01%
Paradigm Financial Partners, LLC 19,500$26,3250.01%
Shulman DeMeo Asset Management LLC 15,487$21,6820.01%
Renaissance Technologies 2,556,064$3,5780.01%
View complete list of ENZO BIOCHEM INC shareholders